| Date Filed | Type | Description |
| 09/26/2023 |
SC 13D/A
| ROSE WILLIAM reports a 0% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 09/26/2023 |
4
| ROSE WILLIAM (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed/sold 379,281 shares
@ $0
Disposed/sold 11,618 shares
@ $0
Disposed/sold 19,795 shares
@ $0
Disposed/sold 7,886 shares
@ $0
Disposed/sold 20 shares
@ $0
Disposed/sold 45 shares
@ $0
Disposed/sold 29 shares
@ $0
Disposed/sold 180,909 shares
@ $0
Disposed/sold 129,308 options to buy
@ $0
Disposed/sold 1,732,998 options to buy
@ $0
Disposed/sold 87,776 options to buy
@ $0 |
|
| 08/24/2023 |
4
| ROSE WILLIAM (Director) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Gifted 500,000 shares
@ $0 |
|
| 08/24/2023 |
SC 13D/A
| ROSE WILLIAM reports a 9.1% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 07/31/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/09/2023 |
4
| ROSE WILLIAM (10% Owner) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 4,275 options to buy
@ $93.61, valued at
$400.2k
Granted 1,085 options to buy
@ $93.61, valued at
$101.6k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
SC 13D/A
| ROSE WILLIAM reports a 9.7% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2019 |
4
| ROSE WILLIAM (10% Owner) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Converted 15,869 shares
@ $0
Sold 400 shares
@ $205.1, valued at
$82k
Sold 600 shares
@ $200, valued at
$120k
Sold 2,000 shares
@ $210, valued at
$420k
Sold 591 shares
@ $215.89, valued at
$127.6k
Sold 2,000 shares
@ $210, valued at
$420k
Sold 2,000 shares
@ $211.27, valued at
$422.5k
Sold 2,000 shares
@ $215.32, valued at
$430.6k
Converted 15,869 options to buy
@ $0 |
|
| 11/20/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/14/2019 |
4
| ROSE WILLIAM (10% Owner) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 9,000 options to buy
@ $88.75, valued at
$798.8k
Granted 978 options to buy
@ $88.75, valued at
$86.8k
|
|
| 11/14/2018 |
4
| ROSE WILLIAM (10% Owner) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed of 811,546 shares
@ $0
Acquired 811,546 shares
@ $0 |
|
| 11/14/2018 |
4
| ROSE WILLIAM (10% Owner) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed of 811,546 shares
@ $0
Acquired 811,546 shares
@ $0 |
|
| 11/14/2018 |
SC 13D/A
| ROSE WILLIAM reports a 12.2% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 07/31/2018 |
SC 13D/A
| ROSE WILLIAM reports a 12.4% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 06/15/2018 |
4
| ROSE WILLIAM (10% Owner) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $39.48, valued at
$315.8k
Granted 1,958 options to buy
@ $39.48, valued at
$77.3k
|
|
| 12/08/2017 |
4
| ROSE WILLIAM (10% Owner) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed (by will) 67,735 shares
@ $0
Disposed (by will) 1,877,998 options to buy
@ $0 |
|
| 12/08/2017 |
4
| ROSE WILLIAM (10% Owner) has filed a Form 4 on REATA PHARMACEUTICALS INC|
Txns:
| Disposed (by will) 67,735 shares
@ $0
Acquired (by will) 67,735 shares
@ $0
Disposed (by will) 1,877,998 options to buy
@ $0
Acquired (by will) 1,877,998 options to buy
@ $0 |
|
| 12/08/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/01/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/12/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/03/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/07/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/19/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2016 |
SC 13D
| ROSE WILLIAM reports a 34.8% stake in § 240. REATA PHARMACEUTICALS, INC. |
| 06/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |